HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,641-2,652 of 7,264
Device study icon
Active Not RecruitingNCT05596318

Perinatal Research on Improving Sleep and Mental Health

Official study title

Efficacy of Digital Cognitive Behavior Therapy for Insomnia for the Prevention of Perinatal Depression

This study is no longer accepting new participants.

In San Francisco
DepressionDevice studyAges 18+
Countries
United States
Sponsor
University of California, San Francisco
Drug study icon
CompletedNCT02505984

Preventing Postpartum Depression With Intranasal Oxytocin

Official study title

Testing the Efficacy of Intranasal Oxytocin for the Prevention of Postpartum Depression and PTSD

This study has finished and is no longer accepting participants.

In Boston
Depression, AnxietyMedication studyAges 18–50
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Device study icon
CompletedNCT05869708

PRISM Neurofeedback Training for MDD Anhedonic Patients

Official study title

Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes

This study has finished and is no longer accepting participants.

In Belmont
DepressionDevice studyAges 22–65
Countries
United States
Sponsor
GrayMatters Health Ltd.
Drug study icon
CompletedNCT00640562

Quetiapine Extended Release Depression Symptoms

Official study title

Comparison of Quetiapine Extended-Release (Seroquel XR™) and Risperidone in the Treatment of Depressive Symptoms, in Schizophrenic or Schizoaffective Patients: A Randomized, Open Label, Flexible-dose, Parallel Group, Non Inferiority, 12-week Study

This study has finished and is no longer accepting participants.

Multiple locations, including Fermo
Depression, SchizophreniaMedication studyAges 18–65
Countries
Italy
Sponsor
AstraZeneca
Behavioral study icon
CompletedNCT04150718

Role of Slow-wave Activity and Plasticity in MDD

Official study title

Investigating the Role of Slow-wave Activity as a Marker of Impaired Plasticity in Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Philadelphia
DepressionBehavioural studyAges 25–50
Countries
United States
Sponsor
University of Pennsylvania

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.